Intravenous Odatroltide for Acute Ischemic Stroke Within 24 Hours of Onset: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
A-Ching Chao, Tsong-Hai Lee, Luther C Pettigrew, Y. Hannawi, Hung-Yu Huang, Nai-Fang Chi, L. Chan, Po-Lin Chen, Thomas Devlin
Drug Design, Development and Therapy